Aethlon Medical Inc (AEMD) income statement
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Aethlon Medical Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -142.9%
Financial strength
- Current ratio
- 5.42
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 476.2%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.70
- Dividend yield
- –
See a number that looks wrong?